{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:29:03Z","timestamp":1790116143476,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005716","name":"Babol University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.lfs.2021.119884","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T23:23:27Z","timestamp":1628637807000},"page":"119884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and \u03b1-smooth muscle actin (\u03b1-SMA) gene expression"],"prefix":"10.1016","volume":"284","author":[{"given":"Asma","family":"Ahrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Najafzadehvarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Taravati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tohidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2021.119884_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000445269","article-title":"New developments on the treatment of liver fibrosis","volume":"34","author":"Koyama","year":"2016","journal-title":"Dig. Dis."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.119884_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2005.06.014","article-title":"Mechanisms of liver fibrosis","volume":"364","author":"Tsukada","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2021.119884_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2021.119884_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20071570","article-title":"Liver fibrosis","volume":"411","author":"Wallace","year":"2008","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.lfs.2021.119884_bb0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cells9010024","article-title":"Metabolic hallmarks of hepatic stellate cells in liver fibrosis","volume":"9","author":"Khomich","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.lfs.2021.119884_bb0030","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/his.13665","article-title":"Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease","volume":"73","author":"Munsterman","year":"2018","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.lfs.2021.119884_bb0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10616-016-9948-3","article-title":"Regulation of matrix metalloproteinase-1 and alpha-smooth muscle actin expression by interleukin-1 alpha and tumour necrosis factor alpha in hepatic stellate cells","volume":"69","author":"Inoue","year":"2017","journal-title":"Cytotechnology"},{"issue":"3","key":"10.1016\/j.lfs.2021.119884_bb0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.surg.2019.10.013","article-title":"Hepatic glypican-3 and alpha-smooth muscle actin overexpressions reflect severity of liver fibrosis and predict outcome after successful portoenterostomy in biliary atresia","volume":"167","author":"Udomsinprasert","year":"2020","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.lfs.2021.119884_bb0045","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/BF01308606","article-title":"a-smooth-muscle actin expression in normal and fibrotic human livers","volume":"38","author":"Yamaoka","year":"1993","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2021.119884_bb0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.lfs.2021.119884_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cbi.2019.01.029","article-title":"Dimethylfumarate ameliorates hepatic injury and fibrosis induced by carbon tetrachloride","volume":"302","author":"Mostafa","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.lfs.2021.119884_bb0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10787-017-0329-0","article-title":"Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis","volume":"26","author":"de Fran\u00e7a","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2021.119884_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0383-6","article-title":"Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles","volume":"13","author":"Yuan","year":"2015","journal-title":"J. Transl. Med."},{"issue":"41","key":"10.1016\/j.lfs.2021.119884_bb0070","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.3748\/wjg.v26.i41.6304","article-title":"Efficacy and safety of anti-hepatic fibrosis drugs","volume":"26","author":"Damiris","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.119884_bb0075","article-title":"Update on berberine in nonalcoholic fatty liver disease","volume":"2013","author":"Liu","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"10","key":"10.1016\/j.lfs.2021.119884_bb0080","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bcp.2012.07.018","article-title":"Berberine: new perspectives for old remedies","volume":"84","author":"Tillhon","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119884_bb0085","article-title":"Berberine inhibition of fibrogenesis in a rat model of liver fibrosis and in hepatic stellate cells","volume":"2016","author":"Wang","year":"2016","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.lfs.2021.119884_bb0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","article-title":"Current knowledge and pharmacological profile of berberine: an update","volume":"761","author":"Kumar","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2021.119884_bb0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect","volume":"63","author":"Acharya","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2021.119884_bb0100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7314\/APJCP.2014.15.2.517","article-title":"PLGA-based nanoparticles as cancer drug delivery systems","volume":"15","author":"Tabatabaei Mirakabad","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.lfs.2021.119884_bb0105","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2010"},{"issue":"5","key":"10.1016\/j.lfs.2021.119884_bb0110","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.nano.2016.01.013","article-title":"Cellular distribution of injected PLGA-nanoparticles in the liver","volume":"12","author":"Park","year":"2016","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.lfs.2021.119884_bb0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/polym11020304","article-title":"Chitosan-modified PLGA nanoparticles for control-released drug delivery","volume":"11","author":"Lu","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.lfs.2021.119884_bb0120","series-title":"Synthesis and Characterization of Poly (D, L-lactide-co-glycolide) Copolymer","author":"Erbetta","year":"2012"},{"issue":"18","key":"10.1016\/j.lfs.2021.119884_bb0125","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1039\/c2sm07236j","article-title":"Development of formaldehyde-free agar\/gelatin microcapsules containing berberine HCl and gallic acid and their topical and oral applications","volume":"8","author":"Lam","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.lfs.2021.119884_bb0130","series-title":"International Scholarly Research Notices, 2012","article-title":"Encapsulation of berberine in nano-sized PLGA synthesized by emulsification method","author":"Khemani","year":"2012"},{"key":"10.1016\/j.lfs.2021.119884_bb0135","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.2147\/IJN.S145951","article-title":"Nanoparticles for the treatment of liver fibrosis","volume":"12","author":"Surendran","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.lfs.2021.119884_bb0140","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11427-013-4568-z","article-title":"Learning from berberine: treating chronic diseases through multiple targets","volume":"58","author":"Yao","year":"2015","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2021.119884_bb0145","first-page":"1","article-title":"Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119884_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cbi.2018.08.016","article-title":"Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats","volume":"294","author":"Eissa","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.lfs.2021.119884_bb0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.lfs.2013.12.211","article-title":"Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase","volume":"98","author":"Li","year":"2014","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.lfs.2021.119884_bb0160","first-page":"2668","article-title":"Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice","volume":"11","author":"Luo","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.lfs.2021.119884_bb0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1681.2007.04819.x","article-title":"Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors","volume":"35","author":"Zhang","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2021.119884_bb0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2015.11.003","article-title":"Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis","volume":"221","author":"Lin","year":"2016","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.lfs.2021.119884_bb0175","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181457","article-title":"Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy","volume":"5","author":"Wan","year":"2018","journal-title":"R. Soc. Open Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521008717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521008717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:20:29Z","timestamp":1752567629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521008717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":35,"alternative-id":["S0024320521008717"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119884","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and \u03b1-smooth muscle actin (\u03b1-SMA) gene expression","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119884"}}